Scheduling GnRH antagonist cycles by a short course of oral estradiol administration during early follicular phase: a comparative study with non-scheduled cycles

2015 ◽  
Vol 31 (6) ◽  
pp. 465-468 ◽  
Author(s):  
Kiper Aslan ◽  
Berrin Avci ◽  
Gurkan Uncu ◽  
Seda Saribal ◽  
Baris Ata
Keyword(s):  
Comparative Study ◽  
Gnrh Antagonist ◽  
Follicular Phase ◽  
Short Course ◽  
Early Follicular Phase

scholarly journals Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols

2006 ◽  
Vol 21 (10) ◽  
pp. 2593-2600 ◽  
Author(s):  
K. Lossl ◽  
A. N. Andersen ◽  
A. Loft ◽  
N. L. C. Freiesleben ◽  
S. Bangsboll ◽  
...  
Keyword(s):  
Aromatase Inhibitor ◽  
Gnrh Antagonist ◽  
Follicular Phase ◽  
Down Regulation ◽  
Early Follicular Phase

scholarly journals Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With “Unpredictable” Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol

2021 ◽  
Vol 12 ◽  
Author(s):  
Chunhui Zhang ◽  
Fangrong Wu ◽  
Zexuan Wu ◽  
Bolan Sun ◽  
Cheng Chen ◽  
...  
Keyword(s):  
Serum Level ◽  
Gnrh Antagonist ◽  
Follicular Phase ◽  
Gonadotropin Releasing Hormone ◽  
Icsi Cycle ◽  
Early Follicular Phase ◽  
Gnrh Antagonist Protocol ◽  
Antagonist Protocol ◽  
Hcg Trigger

PurposeTo compare the effects of early and mid-late follicular phase administration of 150 IU of human chorionic gonadotropin (hCG) on gonadotropin-releasing hormone (GnRH) antagonist protocol in “unpredictable” poor ovarian response (POR) women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment.MethodsA retrospective single-center cohort study was conducted on 67 patients with “unpredictable” POR in their first IVF/ICSI cycle receiving GnRH antagonist protocol. Patients were treated with a second IVF/ICSI cycle using the same GnRH antagonist protocol with the same starting dose of recombinant follicle-stimulating hormone (rFSH) as the first cycle; a daily dose of 150 IU of hCG was administrated on either stimulation day 1 (Group A, n = 35) or day 6 (Group B, n = 32). The number of oocytes retrieved, number of usable embryos, serum level of estradiol (E2) on day of hCG trigger, and clinical pregnant outcomes were studied.ResultsThe addition of 150 IU of hCG on either the first day or sixth day of stimulation increases the serum level of E2, luteinizing hormone (LH), and hCG on the day of hCG trigger. Only the use of 150 IU of hCG on the first stimulation day improved the number of oocytes retrieved, mature of oocytes, and usable embryos, but not the addition of hCG on stimulation day 6. Implantation rate, clinical pregnancy rate, and ongoing pregnancy rate showed an increasing trend in patients receiving 150 IU of hCG in the early phase compared with mid-late phase, even thought there was no statistically significant difference.ConclusionsOur study demonstrated that adding 150 IU of hCG in subsequent GnRH antagonist cycle in “unpredictable” poor responders is associated with the improvement of response to stimulation. Furthermore, early follicular phase addition of 150 IU of hCG significantly increased the number of oocytes retrieved and usable embryos than did the mid-late addition of the same dose.

scholarly journals The role of temporal changes in endometrial blood flow in natural and hormone replacement cycles with vitrified-warmed embryo transfer

2019 ◽  
Author(s):  
Kuniaki Ota ◽  
Toshifumi Takahashi ◽  
Satoru Shiraishi ◽  
Hideki Mizunuma
Keyword(s):  
Blood Flow ◽  
Embryo Transfer ◽  
Hormone Replacement ◽  
Follicular Phase ◽  
Natural Cycle ◽  
Uterine Blood Flow ◽  
Early Follicular Phase ◽  
Endometrial Blood Flow ◽  
Hcg Trigger ◽  
Natural Cycles

Abstract Background Uterine blood flow promotes endometrial development and subsequent implantation of fertilized eggs. We examined the temporal changes in uterine blood flow during natural and hormone replacement (HRT) cycles and clarified the relationship between uterine blood flow and assisted reproductive technology outcomes for vitrified-warmed embryo transfer (ET). Methods This was a retrospective cohort study. A total of 60 patients with vitrified-warmed ET were assigned to two groups according to the endometrial preparation: natural cycle (28 patients) or HRT cycle (32 patients). The uterine endometrial blood flow was evaluated using measurements of the radial artery resistance index (RA-RI) during the early follicular phase, the days of the human chorionic gonadotropin (hCG) trigger during a natural cycle or the start of progesterone administration during the HRT cycle, and the day of ET. We statistically and longitudinally measured and evaluated the RA-RI values of all individual patients. Results During natural cycles, the RA-RI on the day of ET was significantly higher than that during the early follicular phase. During HRT cycles, the RA-RI on the day of ET was also significantly increased compared to that during the early follicular phase. We validated the efficacy of the RA-RI values for predicting the possibility of pregnancy with vitrified-warmed ET. During natural cycles, the area under the receiver-operating characteristic curves (AUCs) for the early follicular phase, the day of hCG trigger, and the day of ET were 0.75 (95% confidence interval [CI], 0.57–0.93), 0.69 (95% CI, 0.49–0.88), and 0.60 (95% CI, 0.36–0.84), respectively. During HRT cycles, AUCs for the early follicular phase, the day of starting progesterone administration, and the day of ET were 0.60 (95% CI, 0.40–0.81), 0.60 (95% CI, 0.39–0.87), and 0.58 (95% CI, 0.37–0.79), respectively. Conclusions The uterine RA-RI increased at approximately the time of the implantation window compared to that of the early follicular phase during both natural and HRT cycles with vitrified-warmed ET. Our findings suggest that RA-RI during the early follicular phase might be effective and useful for deciding whether to choose the natural or HRT cycle for vitrified-warmed ET.

Changes in hormonal concentrations after different heavy-resistance exercise protocols in women

1993 ◽  
Vol 75 (2) ◽  
pp. 594-604 ◽  
Author(s):  
W. J. Kraemer ◽  
S. J. Fleck ◽  
J. E. Dziados ◽  
E. A. Harman ◽  
L. J. Marchitelli ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Rest Period ◽  
Follicular Phase ◽  
Total Testosterone ◽  
Factor I ◽  
Rest Periods ◽  
Early Follicular Phase ◽  
In Series ◽  
Heavy Resistance Exercise ◽  
Blood Variables

Nine eumenorrheic women (age 24.11 +/- 4.28 yr) performed each of six randomly assigned heavy-resistance protocols (HREPs) on separate days during the early follicular phase of the menstrual cycle. The HREPs consisted of two series [series 1 (strength, S) and series 2 (hypertrophy, H)] of three protocols, each using identically ordered exercises controlled for load [5 vs. 10 repetitions maximum (RM)], rest period length (1 vs. 3 min), and total work (J) within each three-protocol series. Blood measures were determined pre-, mid- (after 4 of 8 exercises), and postexercise (0, 5, 15, 30, 60, 90, 120 min and 24 and 48 h). In series 1, a significant (P < 0.05) reduction in growth hormone (GH) was observed at 90 min postexercise for all three protocols. In series 2, the 10-RM protocol with 1-min rest periods (H10/1) produced significant increases above rest in GH concentrations at 0, 5, and 15 min postexercise, and the H10/1 and H5/1 protocols demonstrated significant reductions at 90 and 120 min postexercise. Cortisol demonstrated significant increases in response to the S10/3 protocol at 0 min, to the H10/1 protocol at midexercise and at 0 and 5 min postexercise, and to the H5/1 protocol at 5 and 15 min postexercise. No significant changes were observed in total insulin-like growth factor I, total testosterone, urea, or creatinine for any of the HREPs. Significant elevations in whole blood lactate and ammonia along with significant reductions in blood glucose were observed. Hormonal and metabolic blood variables measured in the early follicular phase of the menstrual cycle varied in response to different HREPs. The most dramatic increases above resting concentrations were observed with the H10/1 protocol, indicating that the more glycolytic HREPs may stimulate greater GH and cortisol increases.

Sign in / Sign up

Export Citation Format

Share Document